INS and metabolic dysfunction-associated steatotic liver disease: The activation of the Nrf2 pathway enhances the antioxidant capacity, reduces inflammation and improves insulin sensitivity, alleviating hepatic steatosis and inflammation and slowing NAFLD progression [153].